{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T17:23:15Z","timestamp":1793467395436,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"\u00d6mer G\u00d6KAY ARGADAL"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-12425-5","type":"journal-article","created":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T23:58:48Z","timestamp":1753747128000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Targeting oxidative stress and metal imbalance in cerebral ischemia: the neuroprotective role of sodium valproate"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2310-7567","authenticated-orcid":false,"given":"Mustafa","family":"Ula\u015f","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6943-7476","authenticated-orcid":false,"given":"\u00d6mer","family":"G\u00f6kay Argadal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8752-125X","authenticated-orcid":false,"given":"Ebru","family":"Barda\u015f \u00d6zkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,28]]},"reference":[{"key":"12425_CR1","doi-asserted-by":"crossref","unstructured":"Zhang, L. et.al. Role of mitochondrial calcium uniporter-mediated Ca2\u2009+\u2009and iron accumulation in traumatic brain injury. J. Cell Mol. Med. 23,2995\u20133009 https:\/\/doi.org10.1111\/jcmm.14206. (2019).","DOI":"10.1111\/jcmm.14206"},{"key":"12425_CR2","doi-asserted-by":"crossref","unstructured":"Valko, M., Rhodes, C. J., Moncol, J., Izakovic, M. & Mazur, M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem. Biol. Interact. 160,1\u201340 https:\/\/doi.org10.1016\/j.cbi.2005.12.009. (2006).","DOI":"10.1016\/j.cbi.2005.12.009"},{"key":"12425_CR3","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1007\/s11095-023-03543-8","volume":"40","author":"Y Luo","year":"2023","unstructured":"Luo, Y. Human serum Albumin-enriched clopidogrel bisulfate nanoparticle alleviates cerebral Ischemia- reperfusion injury in rats. Pharm. Res. 40, 1821\u20131833. https:\/\/doi.org\/10.1007\/s11095-023-03543-8 (2023).","journal-title":"Pharm. Res."},{"key":"12425_CR4","doi-asserted-by":"crossref","unstructured":"Alizadeh, A., Dyck, S. M. & Karimi-Abdolrezaee, S. Traumatic Spinal Cord Injury: An Overview of Pathophysiology, Models and Acute Injury Mechanisms. Front Neurol. 10,282 https:\/\/doi.org10.3389\/fneur.2019.00282. (2019).","DOI":"10.3389\/fneur.2019.00282"},{"key":"12425_CR5","doi-asserted-by":"publisher","first-page":"666","DOI":"10.3389\/fneur.2018.00666","volume":"9","author":"J Luo","year":"2018","unstructured":"Luo, J., Wang, T., Gao, P., Krings, T. & Jiao, L. Endovascular treatment of intracranial atherosclerotic stenosis: current debates and future prospects. Front. Neurol. 9, 666. https:\/\/doi.org10.3389\/fneur.2018.00666 (2018).","journal-title":"Front. Neurol."},{"key":"12425_CR6","doi-asserted-by":"crossref","unstructured":"Chen, S. et al. Valproic acid attenuates traumatic spinal cord injury-induced inflammation via STAT1 and NF-\u03baB pathway dependent of HDAC3. J. Neuroinflammation. 15 (150). https:\/\/doi.org10.1186\/s12974-018-1193-6 (2018).","DOI":"10.1186\/s12974-018-1193-6"},{"key":"12425_CR7","doi-asserted-by":"crossref","unstructured":"Shukla, S. & Tekwani, B. L. Histone deacetylases inhibitors in neurodegenerative diseases, neuroprotection and neuronal differentiation. Front. Pharmacol. 11,537 https:\/\/doi.org10.3389\/fphar.2020.00537 (2020).","DOI":"10.3389\/fphar.2020.00537"},{"key":"12425_CR8","doi-asserted-by":"publisher","first-page":"659","DOI":"10.3389\/fphar.2020.00537","volume":"12","author":"J Jankovic","year":"2015","unstructured":"Jankovic, J. & Sherer, T. The role of epigenetics in neurodegenerative diseases. Neurother 12, 659\u2013670. https:\/\/doi.org10.3389\/fphar.2020.00537 (2015).","journal-title":"Neurother"},{"key":"12425_CR9","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1017\/S1461145708009024","volume":"11","author":"X Wu","year":"2008","unstructured":"Wu, X. Histone deacetylase inhibitors up-regulate astrocyte GDNF and BDNF gene transcription and protect dopaminergic neurons. Int. J. Neuropsychopharmacol. 11, 1123\u20131134. https:\/\/doi.org\/10.1017\/S1461145708009024 (2008). https:\/\/doi.org\/DOI","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"12425_CR10","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.3892\/etm.2020.8802","volume":"20","author":"B Terzio\u011flu Bebito\u011flu","year":"2020","unstructured":"Terzio\u011flu Bebito\u011flu, B., O\u011fuz, E. & G\u00f6k\u00e7e, A. Effect of valproic acid on oxidative stress parameters of glutamate-induced excitotoxicity in SH-SY5Y cells. Exp. Ther. Med. 20, 1321\u20131328. https:\/\/doi.org\/10.3892\/etm.2020.8802 (2020).","journal-title":"Exp. Ther. Med."},{"key":"12425_CR11","doi-asserted-by":"publisher","first-page":"36734","DOI":"10.1074\/jbc.M101287200","volume":"276","author":"CJ Phiel","year":"2001","unstructured":"Phiel, C. J. Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J. Biol. Chem. 276, 36734\u201336741. https:\/\/doi.org\/10.1074\/jbc.M101287200 (2001).","journal-title":"J. Biol. Chem."},{"key":"12425_CR12","doi-asserted-by":"publisher","first-page":"926","DOI":"10.2174\/1570159X17666181227165722","volume":"17","author":"M Romoli","year":"2019","unstructured":"Romoli, M. Valproic acid and epilepsy: from molecular mechanisms to clinical evidences. Curr. Neuropharmacol. 17, 926\u2013946. https:\/\/doi.org\/10.2174\/1570159X17666181227165722 (2019).","journal-title":"Curr. Neuropharmacol."},{"key":"12425_CR13","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1124\/jpet.106.113472","volume":"320","author":"SW Park","year":"2007","unstructured":"Park, S. W. Thiazolidinedione class of peroxisome proliferator-activated receptor gamma agonists prevents neuronal damage, motor dysfunction, Myelin loss, neuropathic pain, and inflammation after spinal cord injury in adult rats. J. Pharmacol. Exp. Ther. 320, 1002\u20131012. https:\/\/doi.org\/10.1124\/jpet.106.113472 (2007).","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"12425_CR14","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2478\/s11658-014-0185-5","volume":"3","author":"VI Lushchak","year":"2014","unstructured":"Lushchak, V. I. Free radicals, reactive oxygen species, oxidative stress. Biochem 3 (1), 11\u201326. https:\/\/doi.org\/10.2478\/s11658-014-0185-5 (2014).","journal-title":"Biochem"},{"key":"12425_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/BJ20081386","volume":"417","author":"MP Murphy","year":"2009","unstructured":"Murphy, M. P. How mitochondria produce reactive oxygen species. Biochem. J. 417, 1\u201313. https:\/\/doi.org\/10.1042\/BJ20081386 (2009).","journal-title":"Biochem. J."},{"key":"12425_CR16","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.neuropharm.2017.11.011","volume":"134","author":"P Li","year":"2018","unstructured":"Li, P., Stetler, R. A. & Leak, R. K. Oxidative stress and mitochondrial dysfunction in ischemic brain injury and neurodegeneration. Neuropharmacol 134, 208\u2013217. https:\/\/doi.org\/10.1016\/j.neuropharm.2017.11.011 (2018).","journal-title":"Neuropharmacol"},{"key":"12425_CR17","first-page":"3892","volume":"27","author":"M Ulas","year":"2023","unstructured":"Ulas, M. & Argadal, O. G. Trace element, antioxidant and oxidant levels in spinal cord injury: different perspective on the effects of valproic acid. Eur. Rev. Med. Pharmacol. Sci. 27, 3892\u20133905 (2023).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"12425_CR18","doi-asserted-by":"publisher","first-page":"193","DOI":"10.2217\/rme.14.86","volume":"10","author":"T Chu","year":"2015","unstructured":"Chu, T. Valproic acid- mediated neuroprotection and neurogenesis after spinal cord injury: from mechanism to clinical potential. Regen Med. 10, 193\u2013209. https:\/\/doi.org\/10.2217\/rme.14.86 (2015).","journal-title":"Regen Med."},{"key":"12425_CR19","doi-asserted-by":"publisher","first-page":"396","DOI":"10.3390\/antiox11020396","volume":"11","author":"MC Lin","year":"2022","unstructured":"Lin, M. C., Liu, C. C., Lin, Y. C. & Hsu, C. W. Epigallocatechin gallate modulates essential elements, zn\/cu ratio, hazardous metal, lipid peroxidation, and antioxidant activity in the brain cortex during cerebral ischemia. Antioxid. (Basel). 11, 396. https:\/\/doi.org\/10.3390\/antiox11020396 (2022).","journal-title":"Antioxid. (Basel)"},{"key":"12425_CR20","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1089\/ars.2009.266","volume":"12","author":"RM Adibhatla","year":"2010","unstructured":"Adibhatla, R. M. & Hatcher, J. F. Lipid oxidation and peroxidation in CNS health and disease: from molecular mechanisms to therapeutic opportunities. Antioxid. Redox Signal. 12, 125\u2013169. https:\/\/doi.org\/10.1089\/ars.2009.266 (2010).","journal-title":"Antioxid. Redox Signal."},{"key":"12425_CR21","doi-asserted-by":"publisher","unstructured":"Singh, D. Hidden Pharmacological activities of valproic acid: A new insight. Biomed. Pharmacother. 142 (112021). https:\/\/doi.org\/10.1016\/j.biopha.2021.112021 (2021).","DOI":"10.1016\/j.biopha.2021.112021"},{"key":"12425_CR22","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.tox.2011.03.001","volume":"283","author":"K Jomova","year":"2011","unstructured":"Jomova, K. & &Valko, M. Advances in metal-induced oxidative stress and human disease. Toxicol 283, 65\u201387. https:\/\/doi.org\/10.1016\/j.tox.2011.03.001 (2011).","journal-title":"Toxicol"},{"key":"12425_CR23","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1556\/aphysiol.97.2010.2.7","volume":"97","author":"M Ulas","year":"2010","unstructured":"Ulas, M. & Cay, M. The effects of 17beta-estradiol and vitamin E treatments on oxidative stress and antioxidant levels in brain cortex of diabetic ovariectomized rats. Acta Physiol. Hung. 97, 208\u2013215. https:\/\/doi.org\/10.1556\/aphysiol.97.2010.2.7 (2010).","journal-title":"Acta Physiol. Hung."},{"key":"12425_CR24","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s12011-012-9596-1","volume":"152","author":"KM Fang","year":"2013","unstructured":"Fang, K. M. Trace element, antioxidant activity, and lipid peroxidation levels in brain cortex of gerbils after cerebral ischemic injury. Biol. Trace Elem. Res. 152, 66\u201374. https:\/\/doi.org\/10.1007\/s12011-012-9596-1 (2013).","journal-title":"Biol. Trace Elem. Res."},{"key":"12425_CR25","doi-asserted-by":"publisher","first-page":"3718","DOI":"10.1007\/s12011-020-02497-x","volume":"199","author":"JH Ro","year":"2021","unstructured":"Ro, J. H., Liu, C. C. & Lin, M. C. Resveratrol mitigates cerebral ischemic injury by altering levels of trace elements, toxic metal, lipid peroxidation, and antioxidant activity. Biol. Trace Elem. Res. 199, 3718\u20133727. https:\/\/doi.org\/10.1007\/s12011-020-02497-x (2021).","journal-title":"Biol. Trace Elem. Res."},{"key":"12425_CR26","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1177\/00912700122010528","volume":"41","author":"A Todorova","year":"2001","unstructured":"Todorova, A., Vonderheid-Guth, B. & Dimpfel, W. Effects of tolterodine, trospium chloride, and Oxybutynin on the central nervous system. J. Clin. Pharmacol. 41, 636\u2013644. https:\/\/doi.org\/10.1177\/00912700122010528 (2001).","journal-title":"J. Clin. Pharmacol."},{"key":"12425_CR27","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.mehy.2011.09.019","volume":"77","author":"P Bhattacharya","year":"2011","unstructured":"Bhattacharya, P., Pandey, A. K. & Paul, S. Minocycline and magnesium in combination May be a good therapeutic intervention for cerebral ischemia. Med. Hypotheses. 77, 1129\u20131131. https:\/\/doi.org\/10.1016\/j.mehy.2011.09.019 (2011).","journal-title":"Med. Hypotheses"},{"key":"12425_CR28","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1097\/SCS.0000000000001339","volume":"26","author":"W Li","year":"2015","unstructured":"Li, W. Magnesium sulfate for acute traumatic brain injury. J. Craniofac. Surg. 26, 393\u2013398. https:\/\/doi.org\/10.1097\/SCS.0000000000001339 (2015).","journal-title":"J. Craniofac. Surg."},{"key":"12425_CR29","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.bbr.2022.114163","volume":"437","author":"OO Akintoye","year":"2023","unstructured":"Akintoye, O. O. Zinc supplement reverses short-term memory deficit in sodium benzoate-induced neurotoxicity in male Wistar rats by enhancing anti-oxidative capacity via Nrf 2 up-regulation. Behav. Brain Res. 437, 114\u2013163. https:\/\/doi.org\/10.1016\/j.bbr.2022.114163 (2023).","journal-title":"Behav. Brain Res."},{"key":"12425_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12011-019-01892-3","volume":"196","author":"G Akbari","year":"2020","unstructured":"Akbari, G. Role of zinc supplementation on ischemia\/reperfusion injury in various organs. Biol. Trace Elem. Res. 196, 1\u20139. https:\/\/doi.org\/10.1007\/s12011-019-01892-3 (2020).","journal-title":"Biol. Trace Elem. Res."},{"key":"12425_CR31","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/fcp.12110","volume":"29","author":"A Prakash","year":"2015","unstructured":"Prakash, A., Bharti, K. & Majeed, A. B. Zinc: indications in brain disorders. Fundam Clin. Pharmacol. 29, 131\u2013149. https:\/\/doi.org\/10.1111\/fcp.12110 (2015).","journal-title":"Fundam Clin. Pharmacol."},{"key":"12425_CR32","doi-asserted-by":"publisher","first-page":"9704","DOI":"10.3390\/ijms24119704","volume":"2","author":"I Staneviciene","year":"2023","unstructured":"Staneviciene, I. et al. Effect of organic selenium on the homeostasis of trace elements, lipid peroxidation, and mRNA expression of antioxidant proteins in mouse organs. Int. J. Mol. Sci. 2, 9704. https:\/\/doi.org\/10.3390\/ijms24119704 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"12425_CR33","doi-asserted-by":"publisher","first-page":"109323","DOI":"10.1016\/j.jnutbio.2023.109323","volume":"117","author":"S Ram\u00edrez-Acosta","year":"2023","unstructured":"Ram\u00edrez-Acosta, S. The role of selenium in shaping mice brain metabolome and selenoproteome through the gut-brain axis by combining metabolomics, metallomics, gene expression, and amplicon sequencing. J. Nutr. Biochem. 117, 109323. https:\/\/doi.org\/10.1016\/j.jnutbio.2023.109323 (2023).","journal-title":"J. Nutr. Biochem."},{"key":"12425_CR34","doi-asserted-by":"publisher","first-page":"144984","DOI":"10.1016\/j.cej.2023.144984","volume":"472","author":"Q Yang","year":"2023","unstructured":"Yang, Q., Zhong, Y., Zhang, Z. & Dang, Z. Simultaneous degradation of sulfamethazine and reduction of Cr(VI) by flexible self-supporting Fe-Cu-Al2O3 nanofibrous membranes as heterogeneous catalysts: insights into synergistic effects and mechanisms. J. Chem. Eng. 472, 144984. https:\/\/doi.org\/10.1016\/j.cej.2023.144984 (2023).","journal-title":"J. Chem. Eng."},{"key":"12425_CR35","doi-asserted-by":"publisher","unstructured":"Al-Naama, L. M., Hassan, M. K. & Mehdi, J. K. Association of erythrocytes antioxidant enzymes and their cofactors with markers of oxidative stress in patients with sickle cell anemia. Qatar Med. J. 14 (2016). https:\/\/doi.org\/10.5339\/qmj.2015.14 (2015).","DOI":"10.5339\/qmj.2015.14"},{"key":"12425_CR36","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0300-483X(00)00254-7","volume":"162","author":"M Travacio","year":"2001","unstructured":"Travacio, M., Polo, J. M. & Llesuy, S. Chromium (VI) induces oxidative stress in the mouse brain. Toxicol 162, 139\u2013148. https:\/\/doi.org\/10.1016\/S0300-483X(00)00254-7 (2001).","journal-title":"Toxicol"},{"key":"12425_CR37","doi-asserted-by":"publisher","first-page":"106877","DOI":"10.1016\/j.envint.2021.106877","volume":"158","author":"JP Wise","year":"2022","unstructured":"Wise, J. P., Jr, Young, J. L., Cai, J. & Cai, L. [cr(vi)]urrent Understanding of hexavalent chromium [Cr(VI)] neurotoxicity and new perspectives. Environ. Int. 158, 106877. https:\/\/doi.org\/10.1016\/j.envint.2021.106877 (2022).","journal-title":"Environ. Int."},{"key":"12425_CR38","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1286\/S40795-023-00690-4","volume":"55","author":"D Strausak","year":"2001","unstructured":"Strausak, D., Mercer, J. F., Dieter, H. H., Stremmel, W. & Multhaup, G. Copper in disorders with neurological symptoms: alzheimer\u2019s, menkes, and Wilson diseases. Brain Res. Bull. 55, 175\u2013185. https:\/\/doi.org\/10.1286\/S40795-023-00690-4 (2001).","journal-title":"Brain Res. Bull."},{"issue":"1","key":"12425_CR39","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/S0361-9230(01)00454-3","volume":"9","author":"E Karimi","year":"2023","unstructured":"Karimi, E. et al. The effects of Royal jelly supplementation on oxidative stress, inflammatory mediators, mental health, cognitive function, quality of life, and clinical outcomes of patients with ischemic stroke: study protocol for a randomized controlled trial. BMC Nutr. 9 (1), 32. https:\/\/doi.org\/10.1016\/S0361-9230(01)00454-3 (2023).","journal-title":"BMC Nutr."},{"key":"12425_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2015.02.013","volume":"1606","author":"S Suda","year":"2015","unstructured":"Suda, S. Valproic acid ameliorates ischemic brain injury in hyperglycemic rats with permanent middle cerebral occlusion. Brain Res. 1606, 1\u20138. https:\/\/doi.org\/10.1016\/j.brainres.2015.02.013 (2015).","journal-title":"Brain Res."},{"issue":"6","key":"12425_CR41","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1111\/cns.13993","volume":"14","author":"J Zhou","year":"2023","unstructured":"Zhou, J., Fangma, Y., Chen, Z. & Zheng, Y. Post-stroke neuropsychiatric complications: types, pathogenesis, and therapeutic intervention. Aging Disease. 14 (6), 2127. https:\/\/doi.org\/10.1111\/cns.13993 (2023).","journal-title":"Aging Disease"},{"key":"12425_CR42","doi-asserted-by":"crossref","unstructured":"Pavlou, M. A. S. & Outeiro, T. F. Epigenetics in Parkinson\u2019s disease (ed. Martins-de-Souza, D.) in Neuroepigenomics Aging Dis., 363\u2013390 (Munich Germany 2017).","DOI":"10.1007\/978-3-319-53889-1_19"},{"issue":"9","key":"12425_CR43","doi-asserted-by":"publisher","first-page":"728","DOI":"10.2174\/1389450124666221207090108","volume":"24","author":"D Pal","year":"2023","unstructured":"Pal, D., Sahu, P., Mishra, A. K., Hagelgans, A. & Sukocheva, O. Histone deacetylase inhibitors as cognitive enhancers and modifiers of mood and behavior. Curr. Drug Targets. 24 (9), 728\u2013750. https:\/\/doi.org\/10.2174\/1389450124666221207090108 (2023).","journal-title":"Curr. Drug Targets"},{"key":"12425_CR44","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1124\/pr.111.005512","volume":"65","author":"CT Chiu","year":"2013","unstructured":"Chiu, C. T., Wang, Z., Hunsberger, J. G. & Chuang, D. M. Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorder. Pharmacol. Rev. 65, 105\u2013142. https:\/\/doi.org\/10.1124\/pr.111.005512 (2013).","journal-title":"Pharmacol. Rev."},{"key":"12425_CR45","doi-asserted-by":"publisher","first-page":"695","DOI":"10.2165\/00023210-200216100-00004","volume":"16","author":"E Perucca","year":"2002","unstructured":"Perucca, E. Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience. CNS Drugs. 16, 695\u2013714. https:\/\/doi.org\/1172-7047\/02\/0010-0695 (2002).","journal-title":"CNS Drugs"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12425-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12425-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12425-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T05:50:45Z","timestamp":1757310645000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12425-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,28]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["12425"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-12425-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,28]]},"assertion":[{"value":"15 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The protocol number 2023\/08, EVKEM, was approved by the Ethics Committee of Elazig University Local Ethics Committee of Animal Experiments and Center Elazig Veterinary Control Institute.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"No artificial intelligence or assisted technologies were used in the study\u2019s production.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"AI disclosure"}}],"article-number":"27529"}}